Cargando…
The Role of Aryl Hydrocarbon Receptor and Crosstalk with Estrogen Receptor in Response of Breast Cancer Cells to the Novel Antitumor Agents Benzothiazoles and Aminoflavone
Many estrogen-receptor- (ER-) expressing breast cancers become refractory to ER-based therapies. New antitumor drugs like aminoflavone (AF) and benzothiazoles (Bzs) have been developed and have exquisite antitumor activity in ER+MCF-7 and T47D cells and in a MCF-7 nude mouse model. ER(−) breast canc...
Autores principales: | Callero, Mariana A., Loaiza-Pérez, Andrea I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262585/ https://www.ncbi.nlm.nih.gov/pubmed/22295239 http://dx.doi.org/10.4061/2011/923250 |
Ejemplares similares
-
Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells
por: Brinkman, Ashley M, et al.
Publicado: (2014) -
Reactivation of Estrogen Receptor α by Vorinostat Sensitizes Mesenchymal-Like Triple-Negative Breast Cancer to Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor
por: Stark, Karri, et al.
Publicado: (2013) -
Estrogen receptor and aryl hydrocarbon receptor signaling pathways
por: Matthews, Jason, et al.
Publicado: (2006) -
Crosstalk between Aryl Hydrocarbon Receptor and Glucocorticoid Receptor in Human Retinal Pigment Epithelial Cells
por: Jin, Hong Lan, et al.
Publicado: (2017) -
The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells
por: O'Donnell, E F, et al.
Publicado: (2014)